Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
S.G. Warburg & Co. was a preeminent British merchant bank that played a significant role in the global financial landscape and the life sciences sector as a leading advisor. Founded in 1946 by Siegmund Warburg, the firm became a dominant force in corporate finance, particularly known for its expertise in mergers and acquisitions within the pharmaceutical industry. Most notably, the firm acted as the lead financial advisor to Glaxo during its landmark acquisition of Wellcome in 1995, a transaction that fundamentally reshaped the pharmaceutical market. S.G. Warburg was acquired by Swiss Bank Corporation (SBC) in 1995, eventually becoming a core component of the modern UBS investment banking division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on S.G. Warburg.